Dow Up 0.15% Nasdaq Up 0.21%

Repros Therapeutics Inc. (RPRX)

-NasdaqCM
12.88 Down 1.51(10.49%) Sep 17, 4:00PM EDT
|After Hours : 13.05 Up 0.17 (1.32%) Sep 17, 7:36PM EDT
Prev Close:14.39
Open:14.43
Bid:12.88 x 200
Ask:13.25 x 1000
1y Target Est:31.17
Beta:-0.64
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:12.50 - 14.59
52wk Range:12.50 - 29.79
Volume:1,817,058
Avg Vol (3m):515,953
Market Cap:297.64M
P/E (ttm):N/A
EPS (ttm):-1.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RPRX

Comparison

Symbol% ChgMkt Cap
RPRXDown 10.49%297.64M
ABTUp 1.12%65.23B
ACTDown 0.70%62.65B
AUXLUp 44.89%1.57B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.53
Quarterly EPS Est (Sep-14) :-0.39
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.31

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Repros Therapeutics Inc., a development stage biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback